Insulin-like growth factor I-dependent regulation of prolidase activity in cultured human skin fibroblasts.
Prolidase [E.C.3.4.13.9] is a cytosolic exopeptidase that catalyses the hydrolysis of C-terminal proline containing dipeptides or tripeptides. The enzyme plays an important role in the recycling of proline for collagen synthesis. Increase in enzyme activity is correlated with increased rates of collagen turnover but the mechanism and endpoints by which this enzyme is regulated remain largely unknown. We have found that insulin-like growth factor-I (IGF-I), potent stimulator of collagen biosynthesis, induces prolidase activity in cultured human skin fibroblasts. Supporting evidence comes from the following observations: (1) Serum of fasted rats, (IGF-I, 72 +/- 16 ng/ml) showed about 50% reduced ability to stimulate prolidase activity and collagen biosynthesis in confluent fibroblasts in comparison to the effect of control rat serum (IGF-I, 168 +/- 29). (2) An addition of IGF-I (100 ng/ml) to fasted rat serum restored its ability to stimulate prolidase activity and collagen biosynthesis to control values. (3) In confluent human skin fibroblasts, cultured for 48 h with serum free medium prolidase activity was decreased to 50% of control cells, cultured in the presence of normal rat serum. Supplementation of serum free medium with EGF, PDGF and IGF-I (factors that can replace growth promoting activity of serum) stimulated prolidase activity to control values while the medium deprived IGF-I had no such effect. (4) The relative differences in prolidase activity due to specific treatment of confluent cells with above growth factors were accompanied by parallel differences in the amount of the enzyme protein recovered from these cells as shown by western immunoblot analysis. Thus we conclude that prolidase activity is regulated by IGF-I in confluent fibroblasts.